Tag: Idiopathic pulmonary fibrosis

Tvardi Therapeutics initiates REVERTIPF trial in idiopathic pulmonary fibrosis

businessnewstoday- September 2, 2023

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in the development of STAT3 inhibitors, has reached a significant milestone by dosing the first patients in ... Read More

BMS-986278 succeeds in phase 2 idiopathic pulmonary fibrosis trial, says Bristol Myers Squibb

businessnewstoday- May 22, 2023

Bristol Myers Squibb (BMS) said that BMS-986278 has succeeded in lowering the rate of lung function decline in idiopathic pulmonary fibrosis patients in a phase ... Read More

Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal

businessnewstoday- February 23, 2023

Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to merge in an all-stock deal that values ... Read More

GRI Bio, Vallon Pharmaceuticals to merge for advancing NKT cell regulators

Raghuram Kadari- December 15, 2022

GRI Bio, a privately held clinical stage biotech company, will merge with a wholly-owned subsidiary of Nasdaq-listed Vallon Pharmaceuticals in an all-stock transaction. The combined ... Read More

AbbVie acquires UK biotech company DJS Antibodies for $255m

Raghuram Kadari- October 21, 2022

AbbVie has acquired DJS Antibodies, a privately-held UK-based biotech company, in an all-cash transaction valued at approximately $255 million, in a move to further strengthen ... Read More

Redx Pharma gets $9m as AstraZeneca initiates AZD5055 phase 1 trial

pallavi123- January 3, 2022

UK-based biotech company Redx Pharma said that it has received a milestone payment of $9 million from AstraZeneca following the initiation of a phase 1 ... Read More

Glenmark Pharmaceuticals gets FDA approval for Nintedanib Capsules

pallavi123- June 28, 2021

Glenmark Pharmaceuticals Ltd said that it has secured tentative approval from the US Food and Drug Administration (FDA) for Nintedanib Capsules, 100mg, and 150mg. Nintedanib ... Read More

Galecto raises $64m to develop fibrosis and cancer treatments

pharmanewsdaily- September 26, 2020

Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments for fibrosis and cancer. Led by Soleus ... Read More

Tenzing to acquire clinical-stage pharma company Reviva Pharmaceuticals

pharmanewsdaily- July 21, 2020

Tenzing Acquisition has agreed to acquire Reviva Pharmaceuticals, a California-based clinical-stage pharma company, focused on developing therapies for addressing unmet medical needs in the areas ... Read More

Roche to acquire US biotech company Promedior for $1.4bn

pharmanewsdaily- November 15, 2019

Roche acquisition of Promedior : Swiss drugmaker Roche has agreed to acquire Massachusetts-based biotech company Promedior in a deal worth up to $1.39 billion, as ... Read More